Rapid Micro Biosystems, Inc. Class A RPID

LEXINGTON, Mass., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced plans to participate in the following upcoming investor conferences: Thursday, September 10, 2026 - Lake Street’s 10th Annual Best Ideas Growth (BIG) Conference in New York, NY. The Comp

Moby summary of Rapid Micro Biosystems, Inc.'s Q2 2026 earnings call

Company exceeds Q2 guidance with 11% revenue growth and record gross margin, while reaffirming full-year outlook and advancing key partnerships.

Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -3.85% and +3.26%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Reports second quarter 2026 total revenue of $8.1 million, representing 11% growth compared to the second quarter of 2025 Achieved a significant milestone with the 200th Growth Direct system placed globally; placed four Growth Direct systems and completed nine validations in the second quarter 2026Second quarter consumable revenue increased more than 20% year-over-yearSecond quarter recurring revenue increased 14% year-over-year; comprised 63% of total revenue Reports record second quarter total

LEXINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grants on August 3, 2026, of 90,000 restricted stock units (“RSUs”) of the Company’s Class A common stock (“Common Stock”) and a non-qualified stock option to purchase 170,000 shares

LEXINGTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, will release second quarter 2026 financial results prior to the market open on Friday, August 7, 2026. In conjunction with the release, the Company’s management team will host a webcast conference call a

LEXINGTON, Mass., June 10, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced the grant on June 3, 2026, of 60,000 restricted stock units (“RSUs”) of the Company’s Class A common stock (“Common Stock”) as a material inducement to employment for a new employee. Such

Bain Capital Life Sciences and Armistice Capital are investing approximately $9.8 million, with the potential of up to approximately $32 million in the event the warrants offered in this offering are exercised, to support the future success of the Company. Certain directors and officers of the Company are also investing in a concurrent registered offeringLEXINGTON, Mass., May 18, 2026 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (“Rapid Micro Biosystems”) (Nasdaq: RPID), an innovative life s

Moby summary of Rapid Micro Biosystems, Inc.'s Q1 2026 earnings call

Rapid Micro Biosystems Inc (RPID) reports significant revenue growth driven by system placements and consumables, despite facing margin pressures and increased operating expenses.

Rapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -24.00% and +6.69%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?